Synthesis and characterization of ferrocene containing block copolymers

Narrowly dispersed diblock copolymers containing poly(methyl methacrylate) [PMMA] or poly(nonafluorohexyl methacrylate) [PF9MA] as the first block and poly(ferrocenylmethyl methacrylate) [PFMMA] as the second block, were prepared by anionic polymerization for the first time. Disordered bulk morphologies in the case of PMMA‐b‐PFMMA were observed and explained in terms of low Flory–Huggins interaction parameter (χ ≤ 0.04). In the case of PF9MA‐b‐PFMMA hexagonally packed cylinder morphology (HEX) was substantiated from TEM and SAXS observations. Furthermore, high incompatibility between PF9MA and PFMMA blocks allowed for the formation of well‐ordered ferrocene containing cylinders on silica substrate upon exposure of the thin films to a saturated solvent vapor. It was shown that the cylinder orientation, parallel or perpendicular to the surface, could easily be controlled by appropriate choice of the solvent and without the need for preliminary surface modification, for example by means of grafted brush layer. © 2016 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2017 , 55, 495–503     

不同激光美容治疗技术的临床应用分析

目的探讨不同激光美容治疗技术的临床应用效果。方法选取2014年1月—2016年9月期间温州医科大学附属眼视光医院收治的48例色素暗沉病症和良性皮肤增生相关病症患者作为研究对象,随机分为对照组和观察组,各24例。两组患者均根据美容需求制定YAG激光治疗方案,对照组单纯采用YAG激光(Q一Switehing Nd:YAGLaser Deviee)技术治疗,观察组在对照组基础上增加强脉冲光治疗,观察两组患者治疗1个月后临床疗效、皮肤损伤程度及损伤愈合时间。结果观察组患者激光美容治疗,治疗总有效率为95.83%(23/24),显著高于对照组(79.17%,19/24),组间差异有统计学意义(P0.05)。观察组皮肤损伤愈合时间(11.36±5.69)d显著低于对照组(15.23±6.58)d,组间差异有统计学意义(P0.05)。观察组和对照组患者两组皮肤损伤程度比较,无显著差异P0.05,无统计学意义。结论 YAG激光联合强脉冲光技术应用于临床医学美容治疗效果较好,且缩短了患者恢复时间,该激光美容治疗技术临床应用可靠。     

Synthesis of spiro[indoline‐3,3′‐pyrrolizines] by 1,3‐dipolar reactions between isatins,l‐proline and electron‐deficient alkenes

Two spiro[indoline‐3,3′‐pyrrolizine] derivatives have been synthesized in good yield with high regio‐ and stereospecificity using one‐pot reactions between readily available starting materials, namely l ‐proline, substituted 1H‐indole‐2,3‐diones and electron‐deficient alkenes. The products have been fully characterized by elemental analysis, IR and NMR spectroscopy, mass spectrometry and crystal structure analysis. In (1′RS ,2′RS ,3SR ,7a′SR )‐2′‐benzoyl‐1‐hexyl‐2‐oxo‐1′,2′,5′,6′,7′,7a′‐hexahydrospiro[indoline‐3,3′‐pyrrolizine]‐1′‐carboxylic acid, C₂₈H₃₂N₂O₄, (I), the unsubstituted pyrrole ring and the reduced spiro‐fused pyrrole ring adopt half‐chair and envelope conformations, respectively, while in (1′RS ,2′RS ,3SR ,7a′SR )‐1′,2′‐bis(4‐chlorobenzoyl)‐5,7‐dichloro‐2‐oxo‐1′,2′,5′,6′,7′,7a′‐hexahydrospiro[indoline‐3,3′‐pyrrolizine], which crystallizes as a partial dichloromethane solvate, C₂₈H₂₀Cl₄N₂O₃·0.981CH₂Cl₂, (II), where the solvent component is disordered over three sets of atomic sites, these two rings adopt envelope and half‐chair conformations, respectively. Molecules of (I) are linked by an O—H…·O hydrogen bond to form cyclic R ₆⁶(48) hexamers of (S ₆) symmetry, which are further linked by two C—H…O hydrogen bonds to form a three‐dimensional framework structure. In compound (II), inversion‐related pairs of N—H…O hydrogen bonds link the spiro[indoline‐3,3′‐pyrrolizine] molecules into simple R ₂²(8) dimers.     

Biomarkers for Alzheimer's Disease – An Overview

Alzheimer's disease (AD) is a complex neurodegenerative disorder with a significant global impact on public health. The emergence of atypical clinical phenotypes challenges traditional diagnostic approaches, necessitating a deeper exploration of biomarkers for accurate identification. The US Food and Drug Administration (FDA) classification of biomarkers and their integration into different stages of AD provide a structured framework for their application in research and clinical settings. Within the context of AD drug development, biomarkers are essential for participant selection, target engagement evaluation, and assessment of pathological hallmarks, including Aβ and tau protein abnormalities. The incorporation of nanoparticles with a biodegradable approach introduces innovative strategies to address the complexities of AD. This paper extensively discusses biomarkers associated with synaptic dysfunction, neuroinflammation, and glial activation, recognizing their significance in elucidating disease mechanisms. Common pathologies such as synuclein and TDP-43 further underscore the multifaceted nature of AD. Current biomarkers for AD diagnosis, encompassing cerebral spinal fluid (CSF) biomarkers and various imaging modalities, reflect the ongoing efforts to enhance early detection and monitoring. Intriguingly, novel biomarkers continue to emerge, offering promising avenues for improved understanding and intervention. Current review provides a comprehensive survey of biomarkers for AD, elucidating their diverse roles across different aspects of the disease. By highlighting their contributions to diagnosis, drug development, and mechanistic insights, this overview underscores the importance of biomarker research in the pursuit of effective AD management and treatment strategies.     

Antihypertensive activity of indole and indazole analogues: A review

Heterocyclic compounds occupy an important position in chemistry because of their wide range of uses in drug design, photochemistry, agrochemicals, and other fields. Indole and indazole scaffolds are available from natural and synthetic sources, and molecules containing these scaffolds have been shown to have various biological effects, including anti-inflammatory, antibacterial, antiviral, antifungal, analgesic, anticancer, antioxidant, anticonvulsant, antidepressant, and antihypertensive activities. Indole and indazole molecules bind to receptors with high affinity, and thus are useful for the study of bioactive compounds involved in multiple pathways. In this review, we highlight the antihypertensive activity and the mechanisms of action of indole and indazole derivatives. In addition, structure–activity relationship studies of the antihypertensive effect are presented.     

Current noise and long time tails in biased disordered random walks

We calculate the mean velocity and the velocity correlation function for a random walk with a uniform bias on a disordered chain. We find a new long time tail in the velocity correlation function due to the combined effects of the bias and of the disorder in the site variables. This long time tail persists to a low-frequency cutoff inversely proportional to the square of the bias. By associating the velocity correlation function with the spectrum of current fluctuations, we calculate the excess low-frequency current noise associated with this long time tail. The spectrum of current fluctuations goes as(I ²/N)f ^–1/2, whereI is the DC current,N is the number of charge carriers, andf is the frequency. The possible connection to 1/f noise is discussed. The calculation is done by a perturbation expansion in the strength of the disorder, but is shown to be exact to all orders for weak enough bias.Supported by a fellowship of the German Academic Exchange Service (DAAD).Supported by the National Science Foundation through Grant No. DMR-8108328 and through the Cornell Materials Science Center.     

Order–disorder phenomena in crystalline phases of compounds E(XMe3)4 where E = C,Si, Ge and X = Si,Sn

We discuss the dynamic solid‐state properties of crystalline phases E(XMe₃)₄ as seen by solid‐state NMR and powder X‐ray diffraction. In the first part we will qualitatively describe some of the NMR tools suitable for such investigations. In the second part we will give examples from the group of solid compounds E(XMe₃)₄ with E = C, Si, Ge and X = Si, Sn. Copyright © 2002 John Wiley & Sons, Ltd.